surmount tirzepatide trials SURMOUNT-2: confers about 15% weight loss in adults with obesity and diabetes SURMOUNT-2: Tirzepatide achieved up to

Lead with flavor, then mention protein as a bonus

doi: 10.1007/S004419900159 51 LimanaFUrbanekKChimentiSQuainiFLeriAKajsturaJet al

In another study , about 31% of participants taking 2.4 mg of semaglutide experienced diarrhea

CrossRef Untargeted Metabolomic Approach Shows No Differences in Subcutaneous Adipose Tissue of Diabetic and Non-Diabetic Subjects Undergoing Bariatric Surgery: An Exploratory Study Carlotta Vizioli, Rosario B

A 32-week randomized, placebo-controlled clinical evaluation of RA-11, an Ayurvedic drug, on osteoarthritis of the knees

Additional tirzepatide-specific concerns include potential thyroid C-cell tumors (seen in rodent studies